Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Coupling . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1125815C details a novel synthesis for quinoline NK-3 antagonists offering higher yields and simplified purification for cost reduction in API manufacturing.
Patent CN101674835A reveals a streamlined synthesis for Galantamine intermediate C2, offering significant cost reduction and improved purity for API manufacturing supply chains.
Patent CN1227250C reveals a safer, scalable route for CDK inhibitor intermediates, eliminating hazardous diazo compounds and chromatography for cost-effective manufacturing.
Patent CN101824012B reveals a novel route for 2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)acetonitrile, offering cost reduction in API manufacturing and high purity.
Patent CN102260273B details novel anti-tumor conjugates. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN104693063A reveals high-yield Tranilast synthesis. Discover cost-effective scalable routes for pharmaceutical intermediates supply chain optimization.
Novel patent CN112390749B details high-yield Cabozantinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111763222B reveals a green route for edoxaban free base. Eliminate Pd catalysts and genotoxic impurities for cost-effective API manufacturing.
Discover the patented preparation method for monocyclic beta-lactam antibiotic intermediates. Enhance your supply chain with high-purity quinoxaline derivatives and scalable processes.
Patent CN109640658A details a scalable synthesis for fungicidal picolinamide intermediates, offering enhanced purity and cost-effective manufacturing solutions.
Discover the novel one-pot method for Rivaroxaban preparation using DMTMM. Achieve high purity and yield while reducing hazardous waste in API manufacturing.
Advanced synthesis of Repaglinide intermediates via DEPBT coupling. Delivers high optical purity and cost reduction in API manufacturing for global supply chains.
Novel alkylation process for (2S)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropionic acid derivatives offers high purity and scalable manufacturing for metabolic syndrome drugs.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Patent CN103387500A reveals a mild catalytic route for Mirabegron intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103804266A offers a streamlined route for vildagliptin intermediates. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturers.
Patent CN113024521B reveals a streamlined 5-step synthesis for Entrectinib, offering high purity and mild conditions for reliable API intermediate supply chains.
Novel method for Nalfuraphine preparation using Boc2O/DMAP system offers high purity and yield, optimizing supply chain for opioid agonist manufacturing.
Patent CN112457293A details a high-yield TBTU/DBU cyclization for Lorlatinib, offering significant cost reduction and purity improvements for pharmaceutical manufacturing.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.